Automated Compounding Devices Market Growth Forecast Through 2030: Market Size And Trends In 2026
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Automated Compounding Devices Market Poised To Hit $3.53 Billion By 2030 With A 7% CAGR
The automated compounding devices market size has experienced robust expansion in recent years. It is projected to increase from $2.51 billion in 2025 to $2.69 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.1%. Historically, this expansion has been driven by factors such as an increasing hospital pharmacy workload, a rising demand for sterile IV preparation, the early adoption of TPN compounding automation, hospital initiatives aimed at reducing compounding errors, and the expansion of inpatient medication therapy volumes.
The automated compounding devices market is projected to experience substantial expansion over the upcoming years, with its valuation anticipated to reach $3.53 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth is driven by several factors, including a heightened focus on ensuring medication safety and compliance, increased capital allocation towards automated pharmacy technologies, a rise in the outsourcing of sterile compounding services, the expanding scope of oncology and critical care drug compounding, and the greater incorporation of digital workflow and reporting systems. Key trends during this period encompass the increased deployment of automated compounding devices to minimize errors in manual medication preparation within hospitals and pharmacies, a heightened need for precise compounding of IV formulations, oncology drugs, and TPN solutions, a noticeable transition towards centralized and high-volume sterile compounding centers within healthcare networks, wider implementation of automated workflow validation and barcode-based verification in compounding procedures, and a growing inclination towards automated compounding platforms that are compact, modular, and upgradable for pharmacy operations.
Get A Free Sample Report With In-Depth Market Insights:
Automated Compounding Devices Market Demand Drivers: What’s Powering Industry Growth?
A rising count of personalized medicines is anticipated to propel the expansion of the automated compounding devices market in the future. This medical approach, known as personalized medicine, involves customizing healthcare choices, methods, interventions, and treatments to align with each patient’s unique attributes. The surge in personalized medicines stems from enhanced genetic comprehension, patient-specific information, and supportive regulations. Automated compounding devices (ACDs) are vital in personalized medicine, facilitating the exact and accurate creation of custom medication blends designed for specific patient requirements. These instruments automate the mixing of diverse pharmaceutical components in precise ratios, which is fundamental for developing personalized therapies. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA granted approval to 16 novel personalized therapies for rare disease patients in 2023, an increase from six in 2022. Consequently, the growing prevalence of personalized medicines is a key factor boosting the growth of the automated compounding devices market.
Automated Compounding Devices Market Segmentation And Category Overview
The automated compounding devices market covered in this report is segmented –
1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software
2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems
3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems
4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)
2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems
Automated Compounding Devices Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies engaged in the automated compounding devices market are increasingly focusing on AI-powered robotic compounding, including AI-enabled IV compounding platform systems that harness artificial intelligence, gravimetric verification, and cloud-based monitoring to automate sterile admixture preparation with considerable precision, instant quality checks, and constant oversight. For instance, in August 2025, Omnicell, a US-based health-technology company, unveiled an AI-enhanced update to its IV compounding system, intended to reinforce safety and accuracy in medication preparation. The updated system incorporates advanced AI-based quality-assurance mechanisms that continuously observe compounding activities, automatically identifying and highlighting any deviations from expected procedures. By introducing this level of automated supervision, Omnicell aims to minimize human error, improve workflow efficiency, and support elevated standards of medication quality in pharmacy operations.
Automated Compounding Devices Market Industry Leaders And Competitive Landscape
Major companies operating in the automated compounding devices market are Becton Dickinson and Company, Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Terumo Corporation, ICU Medical Inc., Omnicell Inc., Tecan Group Ltd., Fagron NV, Swisslog Healthcare, ScriptPro LLC, PharMEDium Services LLC, Loccioni Group SPA, ARxIUM Inc., Codonics Inc., Equashield LLC, Yuyama Mfg Co Ltd, Shanghai Weibond Technology Co Ltd, Medimpex LLC, Medica Inc
View The Full Automated Compounding Devices Market Report:
Automated Compounding Devices Market Regional Analysis And Top Geography
North America was the largest region in the automated compounding devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
